PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

Abstract

Mismatch repair-deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.).